ListedMainboardJLHL
Jupiter Life Line Hospitals Limited
Jupiter Life Line Hospitals Limited is a mainboard IPO raising ₹869 Cr at ₹695 – ₹735 a share. It listed on 18 Sept 2023. We do not have a current price for it yet. It was subscribed 64× in total.
₹735
Issue price
—
Price now
—
Since issue price
18 Sept 2023
Listed on
64×Subscribed (final) · all exchanges
63.7 times more demand than shares on offer
populated partly populated we hold nothing here — the tab says why
Who bid for it
| Investor category | Shares offered | Shares bid for | Subscribed |
|---|---|---|---|
| QIB Banks, funds and other large institutions | 23,72,880 | 44,44,94,800 | 187× |
| Foreign Institutional Investors | no separate quota | 12,88,12,620 | n/a |
| Domestic Financial Institutions | no separate quota | 17,77,85,500 | n/a |
| Mutual funds | no separate quota | 4,24,78,040 | n/a |
| Others | no separate quota | 9,54,18,640 | n/a |
| Non-institutional Wealthy individuals and companies bidding above ₹2 lakh | 18,37,287 | 6,38,46,320 | 35× |
| Non Institutional Investors | 12,24,858 | 4,80,57,860 | 39× |
| Corporates | no separate quota | 7,47,020 | n/a |
| Individuals | no separate quota | 4,11,62,820 | n/a |
| Others | no separate quota | 61,48,020 | n/a |
| Non Institutional Investors | 6,12,429 | 1,57,88,460 | 26× |
| Corporates | no separate quota | 42,840 | n/a |
| Individuals | no separate quota | 1,36,56,460 | n/a |
| Others | no separate quota | 20,89,160 | n/a |
| Retail Ordinary investors bidding up to ₹2 lakh | 42,87,002 | 3,31,19,220 | 7.73× |
| Cut Off | no separate quota | 2,81,31,080 | n/a |
| Price bids | no separate quota | 49,88,140 | n/a |
| Total | 84,97,169 | 54,14,60,340 | 64× |
Sub-categories read no separate quota rather than a dash: the exchange publishes bids at that level but never a reservation against them, so a subscription multiple does not exist — it is not missing data. Bids across both exchanges (NSE and BSE) — the figure usually quoted publicly. Last updated 25 Jul, 07:12 pm IST.
How demand built
We hold no subscription readings for this issue.